The DOI matches its Crossref record; 123 of the 126 references it cites were found in a registry or an index.
Dysregulated relationship of inflammation and oxidative stress in major depression
Open accessAbstract
Chronic inflammation and oxidative stress have been implicated in the pathophysiology of Major Depressive Disorder (MDD), as well as in a number of chronic medical conditions. The aim of this study was to examine the relationship between peripheral inflammatory and oxidative stress markers in un-medicated subjects with MDD compared to non-depressed healthy controls and compared to subjects with MDD after antidepressant treatment. We examined the relationships between IL-6, IL-10, and the IL-6/IL-10 inflammatory ratio vs. F2-isoprostanes (F2-IsoP), a marker of oxidative stress, in un-medicated MDD patients (n=20) before and after 8 weeks of open-label sertraline treatment (n=17), compared to healthy non-depressed controls (n=20). Among the un-medicated MDD subjects, F2-IsoP concentrations were positively correlated with IL-6 concentrations (p<0.05) and were negatively correlated with IL-10 concentrations (p<0.01). Accordingly, F2-IsoP concentrations were positively correlated with the ratio of IL-6/IL-10 (p<0.01). In contrast, in the control group, there were no significant correlations between F2-IsoPs and either cytokine or their ratio. After MDD subjects were treated with sertraline for 8 weeks, F2-IsoPs were no longer significantly correlated with IL-6, IL-10 or the IL-6/IL-10 ratio. These data suggest oxidative stress and inflammatory processes are positively associated in untreated MDD. Our findings are consistent with the hypothesis that the homeostatic buffering mechanisms regulating oxidation and inflammation in healthy individuals become dysregulated in untreated MDD, and may be improved with antidepressant treatment. These findings may help explain the increased risk of comorbid medical illnesses in MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DAMPs that are known to activate NLRP3 are increased in patients with mood disorders, with examples including HSPs, reactive oxygen species and other markers of oxidative stress such as xanthine oxidase, peroxides and F2-isoprostanes51–53.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [52]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In depression, OS plays a crucial role. 131 , 132”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences
Kemp, F. (2003) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.1046/j.1467-9884.2003.t01-2-00383_4.x · Cited by 9,294
Development of a Rating Scale for Primary Depressive Illness
Hamilton, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Preacher, K. J., Curran, P. J., & Bauer, D. J. (2006) · Journal of Educational and Behavioral Statistics · doi:10.3102/10769986031004437 · Cited by 5,044
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Accelerated telomere shortening in response to life stress
Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., & Cawthon, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407162101 · Cited by 3,002
Self-citationThioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Hayes, A. F., & Matthes, J. (2009) · Behavior Research Methods · doi:10.3758/brm.41.3.924 · Cited by 2,452
Research works printed but not linked: 1
- First, M.B., Spitzer, RL., Gibbon, M. (2002). Structured clinical interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York State Psychiatric Institute Biometrics Research.
Cited by
Sorted by citations
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“131,132 The brain is particularly sensitive to OS due to numerous variables, including rapid oxidative energy metabolism (a process through which ROS, which are harmful molecules, are constantly produced), high levels of unsaturated fatty acids (which are vulnerable to lipid peroxidation), and…”
BackgroundOsimo, E. F., Pillinger, T., Rodriguez, I. M., Khandaker, G. M., Pariante, C. M., & Howes, O. D. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.02.010 · Cited by 937
Is depression associated with increased oxidative stress? A systematic review and meta-analysis
Black, C. N., Bot, M., Scheffer, P. G., Cuijpers, P., & Penninx, B. W. J. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.025 · Cited by 711
Kim, Y.-K., Na, K.-S., Myint, A.-M., & Leonard, B. E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.008 · Cited by 620
A Meta-analysis of oxidative stress markers in depression
Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138904 · Cited by 485
Immune mechanisms linked to depression via oxidative stress and neuroprogression
Bakunina, N., Pariante, C. M., & Zunszain, P. A. (2015) · Immunology · doi:10.1111/imm.12443 · Cited by 444
Alcocer-Gómez, E., de Miguel, M., Casas-Barquero, N., Núñez-Vasco, J., Sánchez-Alcazar, J. A., Fernández-Rodríguez, A., & Cordero, M. D. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.10.017 · Cited by 443
Czarny, P., Wigner, P., Galecki, P., & Sliwinski, T. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.036 · Cited by 310
Obstructive sleep apnea, depression and cognitive impairment
Vaněk, J., Praško, J. P., Genzor, S., Ocisková, M., Kantor, K., Holubová, M., Šlepecký, M., Nesnídal, V., Kolek, A., & Sova, M. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.03.017 · Cited by 322
Kopschina Feltes, P., Doorduin, J., Klein, H. C., Juárez-Orozco, L. E., Dierckx, R. A., Moriguchi-Jeckel, C. M., & de Vries, E. F. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711708 · Cited by 279
Lindqvist, D., Epel, E. S., Mellon, S. H., Penninx, B. W., Révész, D., Verhoeven, J. E., Reus, V. I., Lin, J., Mahan, L., Hough, C. M., et al. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.007 · Cited by 285
Self-citationFermented foods, microbiota, and mental health: ancient practice meets nutritional psychiatry
Selhub, E. M., Logan, A. C., & Bested, A. C. (2014) · Journal of Physiological Anthropology · doi:10.1186/1880-6805-33-2 · Cited by 280
Najjar, S., Pearlman, D. M., Devinsky, O., Najjar, A., & Zagzag, D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-142 · Cited by 248
Darrow, S. M., Verhoeven, J. E., Révész, D., Lindqvist, D., Penninx, B. W. J. H., Delucchi, K. L., Wolkowitz, O. M., & Mathews, C. A. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000356 · Cited by 229
Self-citationJiménez‐Fernández, S., Gurpegui, M., Díaz-Atienza, F., Pérez-Costillas, L., Gerstenberg, M., & Correll, C. U. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14r09179 · Cited by 230
Alcocer-Gómez, E., Casas-Barquero, N., Williams, M. R., Romero-Guillena, S. L., Cañadas-Lozano, D., Bullón, P., Sánchez-Alcazar, J. A., Navarro-Pando, J. M., & Cordero, M. D. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.04.028 · Cited by 215
Liu, B., Xu, C., Wu, X., Liu, F., Du, Y., Sun, J., Tao, J., & Dong, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.053 · Cited by 205
Exploration of microbiota targets for major depressive disorder and mood related traits
Chung, Y.-C. E., Chen, H., Chou, H. L., Chen, I., Lee, M., Chuang, L.-C., Liu, Y.-W., Lu, M., Chen, C.-H., Wu, C., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.01.016 · Cited by 194
Shen, F., Song, Z., Xie, P., Li, L., Wang, B., Peng, D., & Zhu, G. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114164 · Cited by 186
Wang, L., Wang, R., Liu, L., Qiao, D., Baldwin, D. S., & Hou, R. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.02.021 · Cited by 192
Shafiee, M., Arekhi, S., Omranzadeh, A., & Sahebkar, A. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.020 · Cited by 185
Aslam, H., Green, J., Jacka, F. N., Collier, F., Berk, M., Pasco, J., & Dawson, S. L. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1544332 · Cited by 179
Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis
Erve, T. J. V. ‘., Kadiiska, M. B., London, S. J., & Mason, R. P. (2017) · Redox Biology · doi:10.1016/j.redox.2017.03.024 · Cited by 174
Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications
Anderson, G., & Maes, M. H. J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660738 · Cited by 148
Oxidative stress markers in affective disorders
Siwek, M., Sowa-Kućma, M., Dudek, D., Styczeń, K., Szewczyk, B., Kotarska, K., Misztak, P., Pilc, A., Wolak, M., & Nowak, G. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71517-2 · Cited by 142
Potential Mechanisms and Clinical Effectiveness of Acupuncture in Depression
Yang, N.-N., Lin, L.-L., Li, Y.-J., Li, H.-P., Cao, Y., Tan, C.-X., Hao, X.-W., Ma, S.-M., Wang, L., & Liu, C.-Z. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210609162809 · Cited by 151
Dionisie, V., Filip, G. A., Manea, M. C., Manea, M., & Riga, S. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00777-5 · Cited by 141
Lehmann, M. L., Weigel, T. K., Poffenberger, C. N., & Herkenham, M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0184-19.2019 · Cited by 138
Pagano, G., Talamanca, A. A., Castello, G., Cordero, M. D., d’Ischia, M., Gadaleta, M. N., Pallardó, F. V., Petrović, S. Ž., Tiano, L., & Zatterale, A. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/541230 · Cited by 139
Inflammatory Depression—Mechanisms and Non-Pharmacological Interventions
Suneson, K., Lindahl, J., Hårsmar, S. C., Söderberg, G., & Lindqvist, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041640 · Cited by 150
Nrf2: An all-rounder in depression
Zuo, C., Cao, H., Song, Y., Gu, Z., Huang, Y., Yang, Y., Miao, J., Zhu, L., Chen, J., Jiang, Y., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102522 · Cited by 139
Barros, M. P., Poppe, S. C., & Bondan, E. F. (2014) · Nutrients · doi:10.3390/nu6031293 · Cited by 134
Winiarska‐Mieczan, A., Kwiecień, M., Jachimowicz-Rogowska, K., Donaldson, J., Tomaszewska, E., & Baranowska‐Wójcik, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032258 · Cited by 144
Bested, A. C., Logan, A. C., & Selhub, E. M. (2013) · Gut Pathogens · doi:10.1186/1757-4749-5-3 · Cited by 121
Sun, Y., Zhang, H., Wu, Z., Yu, X., Yin, Y., Qian, S., Wang, Z., Huang, J., Wang, W., Liu, T., et al. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00371 · Cited by 117
Is biological aging accelerated in drug addiction?
Bachi, K., Sierra, S., Volkow, N. D., Goldstein, R. Z., & Alia‐Klein, N. (2016) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.09.007 · Cited by 123
Lowry, E., Marley, J., McVeigh, J. G., McSorley, E. M., Allsopp, P. J., & Kerr, D. P. (2020) · Nutrients · doi:10.3390/nu12092664 · Cited by 117
Malaise, melancholia and madness: The evolutionary legacy of an inflammatory bias
Raison, C. L., & Miller, A. H. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.04.009 · Cited by 114
Fan, C., Song, Q., Wang, P., Li, Y., Yang, M., & Yu, S. Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02889 · Cited by 109
RetractedWu, Y., Dang, R.-L., Tang, M., Cai, H., Huan-de, L., Liao, D., He, X., Cao, L.-J., Xue, Y., & Jiang, P. (2016) · Nutrients · doi:10.3390/nu8040243 · Cited by 104
Gao, W., Wang, W., Peng, Y., & Deng, Z. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-0389-5 · Cited by 103
van Vuren, E. J., Steyn, S. F., Brink, C. B., Möller, M., Viljoen, F. P., & Harvey, B. H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111200 · Cited by 106
Morris, G., Berk, M., Klein, H. C., Walder, K. R., Gałecki, P., & Maes, M. H. J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9975-2 · Cited by 100
Fan, C., Song, Q., Wang, P., Li, Y., Yang, M., & Yu, S. Y. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00516 · Cited by 100
Lü, Y., Xu, X. M., Jiang, T., Jin, L., Zhao, X., Cheng, J.-H., Jin, X., Ma, J., Piao, H., & Piao, L. X. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.011 · Cited by 97
Accelerated Aging in Schizophrenia Patients: The Potential Role of Oxidative Stress
Okusaga, O. O. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500256 · Cited by 98
Inserra, A., Mastronardi, C. A., Rogers, G. B., Licinio, J., & Wong, M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1359-3 · Cited by 99
Goldstein, J. M., Hale, T. M., Foster, S. L., Tobet, S. A., & Handa, R. J. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0146-1 · Cited by 98
Antidepressant Effect of Paeoniflorin Is Through Inhibiting Pyroptosis CASP-11/GSDMD Pathway
Tian, D., Wang, M., Liu, A., Mei-rong, G., Qiu, C., Wen, Y., Wang, W.-J., Zhang, K., Yang, L., Jia, Y., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02144-5 · Cited by 97
Glymphatic Dysfunction Induced Oxidative Stress and Neuro-Inflammation in Major Depression Disorders
Gu, S., Li, Y., Jiang, Y., Huang, J. H., & Wang, F. (2022) · Antioxidants · doi:10.3390/antiox11112296 · Cited by 98
Are Anxiety Disorders Associated with Accelerated Aging? A Focus on Neuroprogression
Perna, G., Iannone, G., Alciati, A., & Caldirola, D. (2015) · Neural Plasticity · doi:10.1155/2016/8457612 · Cited by 100
Newbury, J. B., Stewart, R. J., Fisher, H. L., Beevers, S. D., Dajnak, D., Broadbent, M. T. M., Pritchard, M., Shiode, N., Heslin, M., Hammoud, R., et al. (2021) · The British Journal of Psychiatry · doi:10.1192/bjp.2021.119 · Cited by 92
Dietary inflammatory index (DII®) and the risk of depression symptoms in adults
Shakya, P. R., Melaku, Y. A., Shivappa, N., Hébert, J. R., Adams, R., Page, A. J., & Gill, T. K. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.12.031 · Cited by 95
Black, C. N., Bot, M., Scheffer, P. G., & Penninx, B. W. J. H. (2016) · Psychological Medicine · doi:10.1017/s0033291716002828 · Cited by 90
Role of enzymatic free radical scavengers in management of oxidative stress in autoimmune disorders
Srivastava, S., Singh, D., Patel, S., & Singh, M. R. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.03.100 · Cited by 86
Li, H., Song, L., Cen, M., Fu, X., Gao, X., Zuo, Q., & Wu, J. L. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.134 · Cited by 85
Morshedi, M., Saghafi‐Asl, M., & Hosseinifard, E.-S. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-019-02169-y · Cited by 81
Śliwiński, T. (2015) · Medical Science Monitor · doi:10.12659/msm.892317 · Cited by 78
“Patients with DD had elevated levels of interleukin-1b (IL-1b), interleukin-6 (IL-6), interleukin-8, and TNFa, which are inflammatory cytokines activate in pro-inflammatory pathways [8–10].”
BackgroundSantos, H., Campos, J. F., dos Santos, C. M., Balestieri, J. B. P., Silva, D. B., Carollo, C. A., Souza, K. D. P., Estevinho, L. M., & dos Santos, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050953 · Cited by 78
Cheng, J., Dong, S., Yi, L., Geng, D., & Liu, Q. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.031 · Cited by 79
How Oxidative Stress Induces Depression?
Ji, N., Lei, M., Chen, Y., Tian, S., Li, C., & Zhang, B. (2023) · ASN NEURO · doi:10.1177/17590914231181037 · Cited by 84
Association of Oxidative Stress with Psychiatric Disorders
Hassan, W., Noreen, H., Gomes, V. D. C., Mohammadzai, I., da Rocha, J. B. T., & Landeira-Fernández, J. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160307145931 · Cited by 76
Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
Rosenblat, J. D., McIntyre, R. S., Alves, G. S., Fountoulakis, K. Ν., & Carvalho, A. F. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150630175044 · Cited by 72
Anti-inflammatory properties of commonly used psychiatric drugs
Patel, S., Keating, B. A., & Dale, R. C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1039379 · Cited by 70
Anjum, S., Qusar, M. S., Shahriar, M., Islam, S. M. A., Bhuiyan, M. A., & Islam, M. R. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916655 · Cited by 71
Neuroinflammation, Gut-Brain Axis and Depression
Evrensel, A., Ünsalver, B. Ö., & Ceylan, M. E. (2019) · Psychiatry Investigation · doi:10.30773/pi.2019.08.09 · Cited by 73
Orientin improves depression‐like behavior and BDNF in chronic stressed mice
Liu, Y., Lan, N., Ren, J., Wu, Y., Wang, S., Huang, X., & Yu, Y. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400753 · Cited by 69
Fan, C., Song, Q., Wang, P., Li, Y., Yang, M., Liu, B., & Yu, S. Y. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.09.028 · Cited by 65
Manosso, L. M., Camargo, A., Dafré, A. L., & Rodrigues, A. L. S. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1853417 · Cited by 64
Guanosine Protects Against Cortical Focal Ischemia. Involvement of Inflammatory Response
Hansel, G., Tonon, A. C., Guella, F. L., Pettenuzzo, L. F., Duarte, T., Duarte, M. M. M. F., Oses, J. P., Achaval, M., & Souza, D. O. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8978-0 · Cited by 65
Steenkamp, L. R., Hough, C. M., Reus, V. I., Jain, F. A., Epel, E. S., James, S. J., Morford, A. E., Mellon, S. H., Wolkowitz, O. M., & Lindqvist, D. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.04.042 · Cited by 62
Self-citationEl‐Naga, R. N., Ahmed, H. I., & Haleem, E. N. A. A. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.05.004 · Cited by 61
Rizk, H. A., Masoud, M. A., & Maher, O. W. (2017) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21977 · Cited by 61
Shafiee, M., Ahmadnezhad, M., Tayefi, M., Arekhi, S., Vatanparast, H., Esmaily, H., Moohebati, M., Ferns, G. A., Mokhber, N., Arefhosseini, S. R., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.05.079 · Cited by 62
Sohrabi, R., Pazgoohan, N., Seresht, H. R., & Amin, B. (2017) · PubMed · doi:10.22038/ijbms.2017.8841 · Cited by 58
Ogłodek, E. A., Szota, A. M., Just, M. J., Moś, D., & Araszkiewicz, A. S. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.06.001 · Cited by 54
Novel investigational drugs targeting IL-6 signaling for the treatment of depression
Fonseka, T. M., McIntyre, R. S., Soczynska, J. K., & Kennedy, S. H. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.998334 · Cited by 56
Assari, S., Sonnega, A. J., Pepin, R. L., & Leggett, A. N. (2016) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-015-0202-z · Cited by 55
Wu, Y. H., Fu, Y., Rao, C., Li, W., Liang, Z., Zhou, C., Shen, P., Cheng, P., Zeng, L., Zhu, D., et al. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.04.032 · Cited by 54
Childhood adversity, social support, and telomere length among perinatal women
Mitchell, A. M., Kowalsky, J. M., Epel, E. S., Lin, J., & Christian, L. M. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.10.003 · Cited by 54
Self-citationKarabatsiakis, A., & Schönfeldt‐Lecuona, C. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00901-7 · Cited by 53
Ribaudo, G., Bortoli, M., Pavan, C., Zagotto, G., & Orian, L. (2020) · Antioxidants · doi:10.3390/antiox9080714 · Cited by 51
The chemistry of gut microbiome in health and diseases
Lau, A., Tan, L. T., Mutalib, N. A., Wong, S. H., Letchumanan, V., & Lee, L. (2021) · Progress In Microbes & Molecular Biology · doi:10.36877/pmmb.a0000175 · Cited by 55
Associations between air pollution and multimorbidity in the UK Biobank: A cross-sectional study
Ronaldson, A., de la Torre, J. A., Ashworth, M. J., Hansell, A., Hotopf, M. H., Mudway, I., Stewart, R. J., Dregan, A., & Bakolis, I. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1035415 · Cited by 48
Andrographolide Reduces Neuroinflammation and Oxidative Stress in Aged Octodon degus
Lindsay, C. B., Zolezzi, J. M., Rivera, D. S., Cisternas, P., Bozinovic, F., & Inestrosa, N. C. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01784-6 · Cited by 48
Huang, Y., Hsu, N.-Y., Lu, K., Lin, Y., Lin, S.-H., Lu, Y.-S., Liu, W.-T., Chen, M.-H., & Sheen, L. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112566 · Cited by 47
Guest, J., BILGIN, A. A. B., Hokin, B. D., Mori, T. A., Croft, K. D., & Grant, R. (2015) · Nutritional Neuroscience · doi:10.1179/1476830515y.0000000041 · Cited by 46
Ortmann, C. F., Réus, G. Z., Ignácio, Z. M., Abelaira, H. M., Titus, S. E., de Carvalho, P., Arent, C. O., dos Santos, M. A. B., Matias, B. I., Martins, M. M., et al. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9596-6 · Cited by 47
Matraszek, R., Chwil, M., Terlecka, P., & Skoczylas, M. M. (2019) · Pharmaceuticals · doi:10.3390/ph12040172 · Cited by 50
Deng, Z., Yuan, C., Yang, J. M., Peng, Y., Wang, W., Wang, Y., & Gao, W. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2018.12.08 · Cited by 45
Do Daughters Really Cause Divorce? Stress, Pregnancy, and Family Composition
Hamoudi, A., & Nobles, J. E. (2014) · Demography · doi:10.1007/s13524-014-0305-x · Cited by 44
Poststroke Neuropsychiatric Symptoms: Relationships with IL-17 and Oxidative Stress
Swardfager, W., Herrmann, N., Andreazza, A. C., Swartz, R. H., Khan, M. M., Black, S. E., & Lanctôt, K. L. (2014) · BioMed Research International · doi:10.1155/2014/245210 · Cited by 44
Tang, C., Zhang, Y., Wang, W., Li, W., & Shi, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9186-2 · Cited by 44
Czarny, P., Kwiatkowski, D., Toma, M., Kubiak, J., Sliwinska, A., Talarowska, M., Szemraj, J., Maes, M., Galecki, P., & Sliwinski, T. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9971-6 · Cited by 43
Black, C. N., Penninx, B. W. J. H., Bot, M., Odegaard, A., Gross, M., Matthews, K. A., & Jacobs, D. R. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.5 · Cited by 44
Debom, G. N., Gazal, M., Soares, M. S. P., do Couto, C. A. T., de Mattos, B. D. S., Lencina, C. L., Kaster, M. P., Ghisleni, G., Tavares, R. G., Braganhol, E., et al. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.10.008 · Cited by 43
Wang, W., Liu, X., Liu, J., Cai, E., Zhao, Y. H., Li, H., Zhang, L., Li, P., & Gao, Y. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b04835 · Cited by 43
Si̇pahi̇, H., Mat, A. F., Özhan, Y., & Aydın, A. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666221223111309 · Cited by 45
Wood, S. K. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120224413 · Cited by 47
Metadata
- Authors
- Rawdin, B. J., Mellon, S. H., Dhabhar, F. S., Epel, E. S., Puterman, E., Su, Y., Burke, H. M., Reus, V. I., Rosser, R., Hamilton, S. P., Nelson, J. C., & Wolkowitz, O. M.
- Affiliations
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Corresponding author
- Wolkowitz, O.M.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 31
- Pages
- 143-152
- ISSN
- 0889-1591 (ISSN-L)
- PMC
- PMC3669232
- OpenAlex
- W2003062523
- Cited by
- 255
- References
- 126
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 18 · 2023: 12 · 2022: 15 · 2021: 15 · 2020: 21 · 2019: 25 · 2018: 21 · 2017: 20 · 2016: 21 · 2015: 21 · 2014: 25 · 2013: 12
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain Behavior and Immunity (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R00HL109247)
- National Institute of Mental Health (R01MH083784, R25MH060482)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, chronic inflammation, oxidative stress, F2-isoprostanes, interleukin-6, IL-10, IL-6/IL-10 ratio, sertraline, antidepressant treatment, untreated depression
- MeSH terms
- Adult, Antidepressive Agents, Major Depressive Disorder, Depressive Disorder, Major, Female, Humans, Inflammation, Male, Middle Aged, Interleukin-6, Interleukin-10, Treatment Outcome, Oxidative Stress, Sertraline
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review